Skip to main content

Commitment to Research

The Baroreflex Activation Therapy for Heart Failure Pivotal Clinical Trial (BeAT-HF)

Clinical trial sites are currently enrolling up to 480 patients in a Phase III Pivotal Trial, evaluating BAROSTIM THERAPY™ for the treatment of heart failure.  

Please visit the  BeAT-HF website or the ClinicalTrials.gov website for more information. 

BeAT-HF

top of page